Wim van Vianen

Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with <i>Candida albicans</i>

Els W. M. van Etten, Marièe Otte-Lambillion, Wim van Vianen et al. · Journal of Antimicrobial Chemotherapy · 1995 · 88 citations

Medicine, Pharmacokinetics, Pharmacology +11

In Vitro Susceptibilities of <i>Madurella mycetomatis</i> to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2 <i>H</i> - Tetrazolium Hydroxide (XTT) Assay

Abdalla O. A. Ahmed, Wendy W. J. van de Sande, Wim van Vianen et al. · Antimicrobial Agents and Chemotherapy · 2004 · 82 citations · Full text

Medicine, Pharmacology, Antimicrobial Pharmacology +11

Distribution, antibiotic susceptibility and tolerance of bacterial isolates in culture-positive cases of endocarditis in The Netherlands

J. T. M. Meer, Wim van Vianen, E. Hu et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1991 · 80 citations

Life Sciences, Infectious Diseases, Microbiology +16

Typing of<i>Acinetobacter calcoaceticus</i>strains isolated from hospital patients by cell envelope protein profiles

Lenie Dijkshoorn, Wim van Vianen, J. E. Degener et al. · Epidemiology and Infection · 1987 · 62 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis

Wim van Vianen, Siem de Marie, Marian T. ten Kate et al. · Journal of Antimicrobial Chemotherapy · 2006 · 51 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17